Elon Musks’s neurotechnology company Neuralink announced on Thursday it has obtained approval from the U.S. Food and Drug Administration (FDA) to carry out a clinical study of brain implants in humans.
It marks the first in-human clinical study for the company.
“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company said in a statement.
“Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!” it added, without providing further details about the trial.
Musk, in response, wrote on Twitter: “Congratulations Neuralink team!”
One thought on “Elon Musk’s Neuralink Gets FDA Approval to Study Brain Implants in Humans”